Our Faculty

Carlos H. Schenck, M.D.

Carlos H. Schenck, M.D.

Minnesota Regional Sleep Disorders Center

Hennepin County Medical Center and

University of Minnesota Medical School

Biography

Dr. Carlos H. Schenck received a B.A. from Johns Hopkins University and M.D. from the State University of New York at Buffalo. He completed a psychiatry residency in 1980 at the University of Minnesota, where he is a professor and senior staff psychiatrist at the Hennepin County Medical Center (HCMC). Since 1982 he has been a staff physician at the Minnesota Regional Sleep Disorders Center at HCMC.

Dr. Schenck and colleagues reported on a new category of parasomnia they named REM sleep behavior disorder (RBD). They were first to report that RBD commonly heralds future parkinsonism, initiating a major international research effort. They identified and named sleep-related (psychogenic) dissociative disorders, sleep-related eating disorder, status dissociatus, ‘Prozac eyes’, epic dream disorder, and parasomnia overlap disorder; formulated the first classification of sexsomnia; and classified the range of parasomnias associated with sleep-disordered breathing.

He was founding President of the International REM Sleep Behavior Disorder Study Group, and a founding member of Sleep Forensics Associates (SFA), which consults on medico-legal cases involving the parasomnia defense. SFA gathered the largest series of sleep forensic cases from a single center, and published on new forensic sleep medicine categories such as parasomnia pseudo-suicide. He was co-chair of the Parasomnias Committee for The International Classification of Sleep Disorders 2nd Edition (ICSD-2); a member of that Committee for the 2014 ICSD-3; and is a member of the AASM Parasomnias Task Force for the ICSD-3 text revision.

Dr. Schenck and his colleague Mark W. Mahowald, M.D. received the William C. Dement Academic Achievement Award from the American Academy of Sleep Medicine in 2007 for their research on RBD and other parasomnias. They received the Sleep Research Society’s Outstanding Scientific Achievement Award in 2010 and the 2017 Sleep Science Award from the American Academy of Neurology for their discovery of RBD and its strong link with parkinsonism. He served as an associate editor of the journal Sleep from 2010-2021, and is on the editorial board of the journal Sleep Science. He has served as an expert peer reviewer for manuscripts submitted to more than 120 medical journals. His books include Paradox Lost: Midnight in the Battleground of Sleep and Dreams, and Sleep: The Mysteries, The Problems, and The Solutions. He was lead editor of the first textbook on rapid-eye-movement sleep behavior disorder.

Dr. Schenck is a Lifetime Honorary Member of La Academia Mexicana de Neurología and Sociedad Española de Sueño. He was on the steering committee for the North America Prodromal Synucleinopathy (NAPS) Consortium, and serves on the executive board of the NAPS2 Consortium. He served as the North America representative of the World Sleep Society, and is chair of the WSS Parasomnias Task Force evaluating diagnostic procedure guidelines for REM sleep behavior disorder.

Publications of Carlos H. Schenck, M.D.

Quick Take Vol. 59

0.50 CMEs
In this Quick Take volume, our expert faculty investigate the link between insomnia symptoms and stroke risk, analyze the long-term effectiveness of antipsychotics in treating schizophrenia, and examine the safety of oral antipsychotics for older adults after surgery. Our experts also assess the benefits and risks of medical cannabis in Parkinson's disease treatment and explore neuroradiological abnormalities in first-episode psychosis.
Faculty: Scott R. Beach, M.D., Gregory Pontone, M.D., M.H.S., Carlos H. Schenck, M.D., Oliver Freudenreich, M.D.
33.01 minutes in 5 audio sections

Quick Take Vol. 58

0.50 CMEs
In this Quick Take volume, our expert faculty examine a range of critical topics, beginning with an exploration of plasma concentrations of SSRI/SNRI post-bariatric surgery and their impact on depressive symptoms. They also investigate the potential of psychedelics as transformative therapeutics in mental health care as well as the efficacy and safety of antidepressants in patients suffering from both depression and other medical diseases. Additionally, the use of daridorexant among patients with chronic insomnia and an international research agenda focusing on clozapine-resistant schizophrenia are discussed.
Faculty: Scott R. Beach, M.D., Carlos H. Schenck, M.D., Oliver Freudenreich, M.D., Sydney M. LeFay, D.O.
35.46 minutes in 5 audio sections

Quick Take Vol. 57

0.50 CMEs
In this Quick Take volume, our expert faculty examine timely research on electroconvulsive therapy as an effective adjunct for clozapine in the treatment of ultra–treatment-resistant schizophrenia, trazodone as a possible first-line treatment for insomnia, and Silexan’s potential benefits for alleviating neuropsychiatric symptoms associated with post-COVID syndrome. Our faculty also discuss studies on medication risks, such as antipsychotic drugs and the risk for acute pancreatitis as well as benzodiazepines and the risk for suicide attempt.
Faculty: Scott R. Beach, M.D., Paul Zarkowski, M.D., Carlos H. Schenck, M.D., Oliver Freudenreich, M.D.
31.18 minutes in 5 audio sections

Parasomnias Triggered by Antidepressant Medications: REM Sleep Behavior Disorder and Restless Legs Syndrome – Interview

0.50 CMEs
In this interview, Dr. Carlos Schenck reviews essential principles in the assessment and management of parasomnias that may be triggered by antidepressants. He identifies common antidepressants that may trigger these and presents differential diagnoses to consider when encountering patients with symptoms of REM sleep behavior disorder. Finally, he discusses evidence-based therapeutic options for these conditions.
Carlos H. Schenck, M.D.
University of Minnesota
37.11 minutes of audio interview

Parasomnias Triggered by Sedative-Hypnotics: Sleepwalking and Sleep-Related Eating Disorder

0.50 CMEs
This time, Dr. Schenck, the career-long sleep disorders expert, brings into light non-REM sleep complex behaviors, which are often missed but strongly impact the lives of our patients. He discusses sleep-related eating disorder, sleepwalking, and sleep driving, while focusing on psychotropic medications associated with the occurrence of pathological behaviors during sleep. Dr. Schenck also presents a risk profile backed by clinical studies from around the world and personal research. The picture is completed by laboratory video recordings of sleepwalking and sleep-related eating disorder.
Carlos H. Schenck, M.D.
University of Minnesota
35.12 minutes in 9 sections

Parasomnias Triggered by Antidepressant Medications: REM Sleep Behavior Disorder and Restless Legs Syndrome

0.75 CMEs
In this presentation, Dr. Schenck shares his career-long expertise in diagnosing and treating the 2 most afflicting but underdiagnosed parasomnias: REM sleep behavior disorder and restless legs syndrome. He discusses the frequency of presentation, the role of antidepressant medication in their occurrence, and how clinicians can help affected patients. In the end, exclusive video recordings from the Minnesota Regional Sleep Disorders Center demonstrate the burden of these parasomnias.
Carlos H. Schenck, M.D.
University of Minnesota
39.32 minutes in 9 sections

Explore our library of over 440 video lectures, podcasts, research summaries and expert interviews.